A new study reveals that patients diagnosed with Type2-diabetes are at an increased risk of developing macrovascular and microvascular complications. Researchers are currently using a drug called Linagliptin which is an anti-diabetic drug that works by increasing the levels of incretins to help control blood sugar levels, especially after meals. According to reports, the cardiovascular[…]
Linagliptin Could be the Answer to Macrovascular Complications Type-2 Diabetics
Anti-Diabetic, Blood Glucose Regulator, Drug Research & Development API, Gliptin Tags: anti-diabeticLinagliptin Dec 01, 2015
Exenatide Capsule Gleans Patent in Israel
Anti-Diabetic, Blood Glucose Regulator, Drug Research & Development API, OTC and Compounding Product, Synthetic Peptide Tags: United States Jun 17, 2015
Known as the brand name Byetta in the United States, which is marketed by AstraZeneca, Exenatide is a GLP-1 analog that is currently offered as an injectable treatment for type 2 diabetes. In mid-January 2015 Oramed Pharmaceuticals was granted a patent in Israel for the oral administration of Exenatide. As an effectual therapy for patients[…]
Is Mirabegron the Next Treatment to Combat Obesity?
Antispasticity Agent, Blood Glucose Regulator, Drug Research & Development API, FDA Approved 2012 Tags: overactive bladder Jan 13, 2015
The January 6, 2015 issue of Cell Metabolism offered exciting news regarding the fight against obesity. Mirabegron, an FDA approved drug for treating overactive bladder, appears to be a viable option for combatting obesity as well. The secret is in Mirabegron’s ability to metabolize brown fat, which generates heat by burning energy, which fights obesity.[…]
Xigduo FDA Approved for Once Daily Type 2 Diabetes Treatment
Anti-Diabetic, Blood Glucose Regulator, FDA Approved 2014, OTC and Compounding Product Tags: Australiatype 2 Diabetes Nov 03, 2014
British-Swedish drugmaker AstraZeneca has been approved by the FDA for its once-a-day Xigduo XR extended-release tablet to treat adults with type 2 diabetes mellitus in the United States. AstraZeneca’s once-daily tablet is indicated as an adjunct therapy to diet and exercise to improve glycaemic control. Xigduo XR is already approved in Australia, and Xigduo is[…]
Trelagliptin Succinate – a Potential Once a Week Type 2 Diabetes Drug
Blood Glucose Regulator, Blood Product, Gliptin Tags: Januviasitagliptintype 2 Diabetes Nov 05, 2012
Cases of Diabetes, particularly type 2 Diabetes have skyrocketed worldwide and in the United States. According to the National Diabetes Information Clearinghouse Diabetes affects 25.8 million people of all ages, or roughly 8.3 percent of the U.S. population. The majority of these cases in the United States, upwards of 90 percent, are of the type[…]
Powerhouse Type 2 Diabetes Medication Exenatide Aids Patients with Weight Loss
Anti-Diabetic, Blood Glucose Regulator, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2016, TEVA API Tags: type 2 diabetes mellitus Sep 11, 2012
Exenatide, CAS number 141758-74-9 is an injectable prescription medication that helps to improve blood sugar, or glucose control in adults with type 2 diabetes mellitus. Exenatide, derived from a compound found in the saliva of the Gila monster, a large lizard native to the southwestern US, is a functional analog of Glucagon-Like Peptide-1 (GLP-1), a naturally[…]
Linagliptin and Metformin Hydrochloride Tag Team to Combat Type 2 Diabetes
Anti-Diabetic, Antibiotic, Blood Glucose Regulator, Drug Research & Development API, Gliptin Tags: LinagliptinMetformin Hydrochloridetype 2 Diabetes Aug 17, 2012
As a chronic disease which occurs when the body does not properly produce, or use the hormone insulin, type 2 diabetes has become a worldwide problem. Roughly 25.8 million Americans and an estimated 366 million people worldwide have diabetes, according to the CDC and 2011 data from the IDF. Type 2 diabetes accounts for 90-95[…]
Metformin Hydrochloride Studies
Anti-Diabetic, Blood Glucose Regulator, OTC and Compounding Product, TEVA API Tags: anti-diabeticLDLMetformin HydrochlorideObesitytype 2 Diabetes Dec 08, 2010
Metformin Hydrochloride is one of the most recommended medicines for the treatment of patients suffering from biguanide or type 2 Diabetes. According to recent studies, Metformin Hydrochloride reduces the LDL and triglyceride levels in the blood and hence it is one of the best medicines for diabetic patients who are also suffering with obesity. Studies[…]